Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy.
Nicotine Tob. Res., Feb;14(2):131-41 (2012)
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.
J Consult Clin Psychol., Feb;78(1):13-23 (2010)
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives.
Nicotine Tob. Res., May;12(5):489-99 (2010)
Using decision tree analysis to identify risk factors for relapse to smoking.
Subst Use Misuse., 46(4):492-510 (2011)
Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials.
Nicotine Tob. Res., Jun;12(6):647-57 (2010)
The Wisconsin Tobacco Quit Line's Fax to Quit program: participant satisfaction and effectiveness.
WMJ., Apr;109(2):79-84 (2010)
A demonstration project for using the electronic health record to identify and treat tobacco users.
WMJ., Dec;109(6):335-40 (2010)
Tobacco withdrawal components and their relations with cessation success.
Psychopharmacology (Berl.)., Aug;216(4):569-78 (2011)
Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations.
Am J Public Health., May;98(5):916-24 (2008)
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM).
Nicotine Tob. Res., Jun;10(6):1009-20 (2008)
The Wisconsin Predicting Patients' Relapse questionnaire.
Nicotine Tob. Res., May;11(5):481-92 (2009)
Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes.
Nicotine Tob. Res., Jul;11(7):785-96 (2009)
Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention.
Nicotine Tob. Res., Dec;8 Suppl 1:S59-67 (2006)
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
Arch. Gen. Psychiatry., Nov;66(11):1253-62 (2009)
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.
Arch. Intern. Med., Dec;169(22):2148-55 (2009)
Depression predicts smoking early but not late in a quit attempt.
Nicotine Tob. Res., Jun;9(6):677-86 (2007)
Efficacy of bupropion alone and in combination with nicotine gum.
Nicotine Tob. Res., Sep;9(9):947-54 (2007)
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.
J Abnorm Psychol., Feb;117(1):94-105 (2008)
Health care provider use of guideline-based smoking cessation interventions: results from the 2003 Wisconsin Tobacco Survey.
WMJ., May;104(4):28-31 (2005)
Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Nicotine Tob. Res., Feb;5(1):99-109 (2003)